Showing results (2781-2790 of 4,096) with videos related to

Sort By:
Pageof 410
Endocrine Journal|September 13, 2013
Antenatal management of recurrent fetal goitrous hyperthyroidism associated with fetal cardiac failure in a pregnant woman with persistent high levels of thyroid-stimulating hormone receptor antibody after ablative therapyTadashi Matsumoto, Kei Miyakoshi, Yoshifumi Saisho, et al.
Endocrine Journal|September 20, 2013
The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levelsKyung-Soo Kim, Hyun-Ju Oh, Dae-Jung Kim, et al.
Endocrine Journal|August 6, 2013
Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapySeiya Shimoda, Shinsuke Iwashita, Shinji Ichimori, et al.
Endocrine Journal|January 15, 2016
A case of lean polycystic ovary syndrome with early stage of type 1 diabetes successfully treated with metforminFumika Shigiyama, Naoki Kumashiro, Takayuki Rikitake, et al.
Endocrine Journal|December 25, 2015
Genome editing: A breakthrough in life science and medicineIzuho Hatada, Takuro Horii
Endocrine Journal|November 20, 2015
Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patientsFeyza Yener Ozturk, Selvinaz Erol, Muhammed Masum Canat, et al.
Endocrine Journal|November 20, 2015
TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patientsKoji Mukasa, Jaeduk Yoshimura Noh, Ai Kouzaki, et al.
Endocrine Journal|December 1, 2015
Chronology of endocrine differentiation and beta-cell neogenesisTakeshi Miyatsuka
Endocrine Journal|August 8, 2015
Early liraglutide treatment improves β-cell function in patients with type 2 diabetes: a retrospective cohort studyYoshinobu Kondo, Shinobu Satoh, Uru Nezu Osada, et al.
Endocrine Journal|October 23, 2015
Proprotein convertase subtilisin/kexin type 9 (PCSK9), soluble lectin-like oxidized LDL receptor 1 (sLOX-1) and ankle brachial index in patients with differentiated thyroid cancerCigdem Ozkan, Mujde Akturk, Alev Eroglu Altinova, et al.
Pageof 410